Definitive Healthcare Corp. (NASDAQ:DH) Shares Purchased by State Street Corp

State Street Corp lifted its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 29.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,399,729 shares of the company’s stock after purchasing an additional 317,952 shares during the period. State Street Corp’s holdings in Definitive Healthcare were worth $6,257,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Point72 DIFC Ltd boosted its position in Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after purchasing an additional 8,215 shares during the period. Intech Investment Management LLC bought a new stake in Definitive Healthcare in the third quarter valued at $55,000. Bleakley Financial Group LLC acquired a new position in shares of Definitive Healthcare during the third quarter valued at $74,000. Glenmede Trust Co. NA grew its position in shares of Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after acquiring an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new stake in shares of Definitive Healthcare in the 3rd quarter worth about $84,000. 98.67% of the stock is owned by institutional investors.

Definitive Healthcare Stock Down 0.5 %

DH stock opened at $4.23 on Friday. The company has a 50 day moving average of $4.38 and a two-hundred day moving average of $4.63. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare Corp. has a 12-month low of $3.19 and a 12-month high of $10.62. The company has a market cap of $488.66 million, a price-to-earnings ratio of -1.36, a PEG ratio of 3.29 and a beta of 1.40.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on DH shares. BTIG Research began coverage on Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price target for the company. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a report on Friday, November 8th. Finally, Stephens assumed coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They set an “equal weight” rating and a $5.00 target price on the stock. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $5.72.

Insider Activity at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the transaction, the insider now owns 433,830 shares in the company, valued at approximately $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 14.84% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.